Fezolinetant is indicated for the treatment of moderate to severe vasomotor symptoms due to menopause.
from FDA,2024.08
Fezolinetant is indicated for the treatment of vasomotor symptoms due to menopau···【more】
Release date:2026-01-05Recommended:160
LuciusVersionofFezolinetant:DosageandAdministration,Indications,PrecautionsIndic···【more】
Release date:2025-12-10Recommended:228
Lucius Version of Fezolinetant: Dosage and Administration, Indications, Precauti···【more】
Release date:2025-12-09Recommended:147